PGP and cancer: In a random screen of commercial compounds, compounds 86 and 87 (Figure 11), which contain a 4-thiazolidinone core structure, selectively killed drug-resistant cancer cells overexpressing P-gp by inducing apoptosis [124,125,126,127].